PARATEK PHARMACEUTICALS, INC. has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan PARATEK PHARMACEUTICALS, INC. PROFIT SHARING 401(K) PLAN
| Measure | Date | Value |
|---|
| 2020 : PARATEK PHARMACEUTICALS, INC. PROFIT SHARING 401(K) PLAN 2020 401k financial data |
|---|
| Unrealized appreciation/depreciation of real estate assets | 2020-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2020-12-31 | $0 |
| Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
| Total transfer of assets to this plan | 2020-12-31 | $0 |
| Total transfer of assets from this plan | 2020-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Expenses. Interest paid | 2020-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2020-12-31 | $0 |
| Total income from all sources (including contributions) | 2020-12-31 | $5,799,563 |
| Total loss/gain on sale of assets | 2020-12-31 | $0 |
| Total of all expenses incurred | 2020-12-31 | $1,842,465 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $1,844,804 |
| Expenses. Certain deemed distributions of participant loans | 2020-12-31 | $0 |
| Value of total corrective distributions | 2020-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $2,438,992 |
| Value of total assets at end of year | 2020-12-31 | $20,863,217 |
| Value of total assets at beginning of year | 2020-12-31 | $16,906,119 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $-2,339 |
| Total income from rents | 2020-12-31 | $0 |
| Total interest from all sources | 2020-12-31 | $5,116 |
| Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $997,012 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $997,012 |
| Assets. Real estate other than employer real property at end of year | 2020-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2020-12-31 | $0 |
| Administrative expenses professional fees incurred | 2020-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2020-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2020-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
| Value of fidelity bond cover | 2020-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
| Contributions received from participants | 2020-12-31 | $1,638,691 |
| Participant contributions at end of year | 2020-12-31 | $55,263 |
| Participant contributions at beginning of year | 2020-12-31 | $73,569 |
| Participant contributions at end of year | 2020-12-31 | $0 |
| Participant contributions at beginning of year | 2020-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2020-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2020-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $46,263 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2020-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2020-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2020-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2020-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2020-12-31 | $0 |
| Other income not declared elsewhere | 2020-12-31 | $0 |
| Administrative expenses (other) incurred | 2020-12-31 | $-2,339 |
| Liabilities. Value of operating payables at end of year | 2020-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2020-12-31 | $0 |
| Total non interest bearing cash at end of year | 2020-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2020-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Income. Non cash contributions | 2020-12-31 | $0 |
| Value of net income/loss | 2020-12-31 | $3,957,098 |
| Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $20,863,217 |
| Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $16,906,119 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2020-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2020-12-31 | $0 |
| Investment advisory and management fees | 2020-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $20,414,433 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $16,576,516 |
| Value of interest in pooled separate accounts at end of year | 2020-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2020-12-31 | $0 |
| Interest on participant loans | 2020-12-31 | $4,356 |
| Income. Interest from loans (other than to participants) | 2020-12-31 | $0 |
| Interest earned on other investments | 2020-12-31 | $0 |
| Income. Interest from US Government securities | 2020-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2020-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2020-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2020-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2020-12-31 | $0 |
| Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2020-12-31 | $393,521 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2020-12-31 | $256,034 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2020-12-31 | $256,034 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2020-12-31 | $760 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2020-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2020-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2020-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2020-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2020-12-31 | $0 |
| Asset value of US Government securities at end of year | 2020-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2020-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $2,358,443 |
| Net investment gain/loss from pooled separate accounts | 2020-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2020-12-31 | $0 |
| Net gain/loss from 103.12 investment entities | 2020-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | Yes |
| Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
| Assets. Invements in employer securities at end of year | 2020-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2020-12-31 | $0 |
| Assets. Value of employer real property at end of year | 2020-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2020-12-31 | $0 |
| Contributions received in cash from employer | 2020-12-31 | $754,038 |
| Employer contributions (assets) at end of year | 2020-12-31 | $0 |
| Employer contributions (assets) at beginning of year | 2020-12-31 | $0 |
| Income. Dividends from preferred stock | 2020-12-31 | $0 |
| Income. Dividends from common stock | 2020-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $1,844,804 |
| Asset. Corporate debt instrument preferred debt at end of year | 2020-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2020-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2020-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2020-12-31 | $0 |
| Contract administrator fees | 2020-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2020-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2020-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2020-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2020-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2020-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2020-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2020-12-31 | $0 |
| Did the plan have assets held for investment | 2020-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
| Aggregate proceeds on sale of assets | 2020-12-31 | $0 |
| Aggregate carrying amount (costs) on sale of assets | 2020-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at end of year | 2020-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2020-12-31 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
| Accountancy firm name | 2020-12-31 | GRAY, GRAY, & GRAY LLP |
| Accountancy firm EIN | 2020-12-31 | 042088368 |
| 2019 : PARATEK PHARMACEUTICALS, INC. PROFIT SHARING 401(K) PLAN 2019 401k financial data |
|---|
| Unrealized appreciation/depreciation of real estate assets | 2019-12-31 | $0 |
| Unrealized appreciation/depreciation of real estate assets | 2019-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2019-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2019-12-31 | $0 |
| Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
| Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
| Total transfer of assets to this plan | 2019-12-31 | $0 |
| Total transfer of assets to this plan | 2019-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Expenses. Interest paid | 2019-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2019-12-31 | $0 |
| Expenses. Interest paid | 2019-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2019-12-31 | $0 |
| Total income from all sources (including contributions) | 2019-12-31 | $6,137,238 |
| Total income from all sources (including contributions) | 2019-12-31 | $6,137,238 |
| Total loss/gain on sale of assets | 2019-12-31 | $0 |
| Total loss/gain on sale of assets | 2019-12-31 | $0 |
| Total of all expenses incurred | 2019-12-31 | $1,807,897 |
| Total of all expenses incurred | 2019-12-31 | $1,807,897 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $1,812,011 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $1,812,011 |
| Expenses. Certain deemed distributions of participant loans | 2019-12-31 | $0 |
| Expenses. Certain deemed distributions of participant loans | 2019-12-31 | $0 |
| Value of total corrective distributions | 2019-12-31 | $0 |
| Value of total corrective distributions | 2019-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $2,942,299 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $2,942,299 |
| Value of total assets at end of year | 2019-12-31 | $16,906,119 |
| Value of total assets at end of year | 2019-12-31 | $16,906,119 |
| Value of total assets at beginning of year | 2019-12-31 | $12,576,778 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $-4,114 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $-4,114 |
| Total income from rents | 2019-12-31 | $0 |
| Total income from rents | 2019-12-31 | $0 |
| Total interest from all sources | 2019-12-31 | $7,660 |
| Total interest from all sources | 2019-12-31 | $7,660 |
| Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $746,977 |
| Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $746,977 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $746,977 |
| Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $746,977 |
| Assets. Real estate other than employer real property at end of year | 2019-12-31 | $0 |
| Assets. Real estate other than employer real property at end of year | 2019-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2019-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2019-12-31 | $0 |
| Administrative expenses professional fees incurred | 2019-12-31 | $0 |
| Administrative expenses professional fees incurred | 2019-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2019-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2019-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2019-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2019-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
| Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
| Value of fidelity bond cover | 2019-12-31 | $500,000 |
| Value of fidelity bond cover | 2019-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
| If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
| Contributions received from participants | 2019-12-31 | $1,657,831 |
| Contributions received from participants | 2019-12-31 | $1,657,831 |
| Participant contributions at end of year | 2019-12-31 | $73,569 |
| Participant contributions at end of year | 2019-12-31 | $73,569 |
| Participant contributions at beginning of year | 2019-12-31 | $60,962 |
| Participant contributions at beginning of year | 2019-12-31 | $60,962 |
| Participant contributions at end of year | 2019-12-31 | $0 |
| Participant contributions at end of year | 2019-12-31 | $0 |
| Participant contributions at beginning of year | 2019-12-31 | $0 |
| Participant contributions at beginning of year | 2019-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2019-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2019-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2019-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2019-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $338,388 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $338,388 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2019-12-31 | $0 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2019-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2019-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2019-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2019-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2019-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2019-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2019-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2019-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2019-12-31 | $0 |
| Other income not declared elsewhere | 2019-12-31 | $0 |
| Other income not declared elsewhere | 2019-12-31 | $0 |
| Administrative expenses (other) incurred | 2019-12-31 | $-4,114 |
| Administrative expenses (other) incurred | 2019-12-31 | $-4,114 |
| Liabilities. Value of operating payables at end of year | 2019-12-31 | $0 |
| Liabilities. Value of operating payables at end of year | 2019-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2019-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2019-12-31 | $0 |
| Total non interest bearing cash at end of year | 2019-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2019-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2019-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Income. Non cash contributions | 2019-12-31 | $0 |
| Income. Non cash contributions | 2019-12-31 | $0 |
| Value of net income/loss | 2019-12-31 | $4,329,341 |
| Value of net income/loss | 2019-12-31 | $4,329,341 |
| Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $16,906,119 |
| Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $16,906,119 |
| Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $12,576,778 |
| Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $12,576,778 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2019-12-31 | $0 |
| Assets. partnership/joint venture interests at end of year | 2019-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2019-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2019-12-31 | $0 |
| Investment advisory and management fees | 2019-12-31 | $0 |
| Investment advisory and management fees | 2019-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $16,576,516 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $16,576,516 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $12,227,229 |
| Value of interest in pooled separate accounts at end of year | 2019-12-31 | $0 |
| Value of interest in pooled separate accounts at end of year | 2019-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2019-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2019-12-31 | $0 |
| Interest on participant loans | 2019-12-31 | $2,749 |
| Interest on participant loans | 2019-12-31 | $2,749 |
| Income. Interest from loans (other than to participants) | 2019-12-31 | $0 |
| Income. Interest from loans (other than to participants) | 2019-12-31 | $0 |
| Interest earned on other investments | 2019-12-31 | $0 |
| Interest earned on other investments | 2019-12-31 | $0 |
| Income. Interest from US Government securities | 2019-12-31 | $0 |
| Income. Interest from US Government securities | 2019-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2019-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2019-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2019-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2019-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2019-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2019-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2019-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2019-12-31 | $0 |
| Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $0 |
| Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-12-31 | $256,034 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-12-31 | $256,034 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-12-31 | $288,587 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-12-31 | $288,587 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-12-31 | $288,587 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-12-31 | $288,587 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2019-12-31 | $4,911 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2019-12-31 | $4,911 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2019-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2019-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2019-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2019-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2019-12-31 | $0 |
| Asset value of US Government securities at end of year | 2019-12-31 | $0 |
| Asset value of US Government securities at end of year | 2019-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2019-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2019-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $2,440,302 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $2,440,302 |
| Net investment gain/loss from pooled separate accounts | 2019-12-31 | $0 |
| Net investment gain/loss from pooled separate accounts | 2019-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2019-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2019-12-31 | $0 |
| Net gain/loss from 103.12 investment entities | 2019-12-31 | $0 |
| Net gain/loss from 103.12 investment entities | 2019-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
| Assets. Invements in employer securities at end of year | 2019-12-31 | $0 |
| Assets. Invements in employer securities at end of year | 2019-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2019-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2019-12-31 | $0 |
| Assets. Value of employer real property at end of year | 2019-12-31 | $0 |
| Assets. Value of employer real property at end of year | 2019-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2019-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2019-12-31 | $0 |
| Contributions received in cash from employer | 2019-12-31 | $946,080 |
| Contributions received in cash from employer | 2019-12-31 | $946,080 |
| Employer contributions (assets) at end of year | 2019-12-31 | $0 |
| Employer contributions (assets) at end of year | 2019-12-31 | $0 |
| Employer contributions (assets) at beginning of year | 2019-12-31 | $0 |
| Employer contributions (assets) at beginning of year | 2019-12-31 | $0 |
| Income. Dividends from preferred stock | 2019-12-31 | $0 |
| Income. Dividends from preferred stock | 2019-12-31 | $0 |
| Income. Dividends from common stock | 2019-12-31 | $0 |
| Income. Dividends from common stock | 2019-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $1,812,011 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $1,812,011 |
| Asset. Corporate debt instrument preferred debt at end of year | 2019-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at end of year | 2019-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2019-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2019-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2019-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2019-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2019-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2019-12-31 | $0 |
| Contract administrator fees | 2019-12-31 | $0 |
| Contract administrator fees | 2019-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2019-12-31 | No |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2019-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2019-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2019-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2019-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2019-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2019-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2019-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2019-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2019-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2019-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2019-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2019-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2019-12-31 | $0 |
| Did the plan have assets held for investment | 2019-12-31 | Yes |
| Did the plan have assets held for investment | 2019-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
| Aggregate proceeds on sale of assets | 2019-12-31 | $0 |
| Aggregate proceeds on sale of assets | 2019-12-31 | $0 |
| Aggregate carrying amount (costs) on sale of assets | 2019-12-31 | $0 |
| Aggregate carrying amount (costs) on sale of assets | 2019-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at end of year | 2019-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at end of year | 2019-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2019-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2019-12-31 | $0 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
| Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
| Accountancy firm name | 2019-12-31 | GRAY, GRAY, & GRAY LLP |
| Accountancy firm name | 2019-12-31 | GRAY, GRAY, & GRAY LLP |
| Accountancy firm EIN | 2019-12-31 | 042088368 |
| Accountancy firm EIN | 2019-12-31 | 042088368 |
| 2018 : PARATEK PHARMACEUTICALS, INC. PROFIT SHARING 401(K) PLAN 2018 401k financial data |
|---|
| Transfers to/from the plan | 2018-12-31 | $0 |
| Total plan liabilities at end of year | 2018-12-31 | $0 |
| Total plan liabilities at beginning of year | 2018-12-31 | $0 |
| Total income from all sources | 2018-12-31 | $2,883,314 |
| Expenses. Total of all expenses incurred | 2018-12-31 | $359,410 |
| Benefits paid (including direct rollovers) | 2018-12-31 | $368,586 |
| Total plan assets at end of year | 2018-12-31 | $12,576,778 |
| Total plan assets at beginning of year | 2018-12-31 | $10,052,874 |
| Value of fidelity bond covering the plan | 2018-12-31 | $500,000 |
| Total contributions received or receivable from participants | 2018-12-31 | $1,294,310 |
| Expenses. Other expenses not covered elsewhere | 2018-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2018-12-31 | $1,990,155 |
| Other income received | 2018-12-31 | $-943,357 |
| Noncash contributions received | 2018-12-31 | $0 |
| Net income (gross income less expenses) | 2018-12-31 | $2,523,904 |
| Net plan assets at end of year (total assets less liabilities) | 2018-12-31 | $12,576,778 |
| Net plan assets at beginning of year (total assets less liabilities) | 2018-12-31 | $10,052,874 |
| Assets. Value of participant loans | 2018-12-31 | $60,962 |
| Total contributions received or receivable from employer(s) | 2018-12-31 | $542,206 |
| Value of certain deemed distributions of participant loans | 2018-12-31 | $0 |
| Value of corrective distributions | 2018-12-31 | $0 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2018-12-31 | $-9,176 |
| 2014 : PARATEK PHARMACEUTICALS, INC. PROFIT SHARING 401(K) PLAN 2014 401k financial data |
|---|
| Transfers to/from the plan | 2014-12-31 | $0 |
| Total plan liabilities at end of year | 2014-12-31 | $0 |
| Total plan liabilities at beginning of year | 2014-12-31 | $0 |
| Total income from all sources | 2014-12-31 | $846,950 |
| Expenses. Total of all expenses incurred | 2014-12-31 | $724,583 |
| Benefits paid (including direct rollovers) | 2014-12-31 | $724,408 |
| Total plan assets at end of year | 2014-12-31 | $7,582,415 |
| Total plan assets at beginning of year | 2014-12-31 | $7,460,048 |
| Value of fidelity bond covering the plan | 2014-12-31 | $500,000 |
| Total contributions received or receivable from participants | 2014-12-31 | $185,063 |
| Expenses. Other expenses not covered elsewhere | 2014-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2014-12-31 | $0 |
| Other income received | 2014-12-31 | $574,791 |
| Noncash contributions received | 2014-12-31 | $0 |
| Net income (gross income less expenses) | 2014-12-31 | $122,367 |
| Net plan assets at end of year (total assets less liabilities) | 2014-12-31 | $7,582,415 |
| Net plan assets at beginning of year (total assets less liabilities) | 2014-12-31 | $7,460,048 |
| Assets. Value of participant loans | 2014-12-31 | $68,350 |
| Total contributions received or receivable from employer(s) | 2014-12-31 | $87,096 |
| Value of certain deemed distributions of participant loans | 2014-12-31 | $0 |
| Value of corrective distributions | 2014-12-31 | $0 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2014-12-31 | $175 |
| 2013 : PARATEK PHARMACEUTICALS, INC. PROFIT SHARING 401(K) PLAN 2013 401k financial data |
|---|
| Transfers to/from the plan | 2013-12-31 | $0 |
| Total plan liabilities at end of year | 2013-12-31 | $0 |
| Total income from all sources | 2013-12-31 | $2,047,029 |
| Expenses. Total of all expenses incurred | 2013-12-31 | $2,726,171 |
| Benefits paid (including direct rollovers) | 2013-12-31 | $2,725,745 |
| Total plan assets at end of year | 2013-12-31 | $7,460,048 |
| Total plan assets at beginning of year | 2013-12-31 | $8,139,190 |
| Value of fidelity bond covering the plan | 2013-12-31 | $500,000 |
| Total contributions received or receivable from participants | 2013-12-31 | $214,578 |
| Expenses. Other expenses not covered elsewhere | 2013-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2013-12-31 | $0 |
| Other income received | 2013-12-31 | $1,738,219 |
| Noncash contributions received | 2013-12-31 | $0 |
| Net income (gross income less expenses) | 2013-12-31 | $-679,142 |
| Net plan assets at end of year (total assets less liabilities) | 2013-12-31 | $7,460,048 |
| Net plan assets at beginning of year (total assets less liabilities) | 2013-12-31 | $8,139,190 |
| Assets. Value of participant loans | 2013-12-31 | $32,579 |
| Total contributions received or receivable from employer(s) | 2013-12-31 | $94,232 |
| Value of certain deemed distributions of participant loans | 2013-12-31 | $0 |
| Value of corrective distributions | 2013-12-31 | $0 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2013-12-31 | $426 |
| 2012 : PARATEK PHARMACEUTICALS, INC. PROFIT SHARING 401(K) PLAN 2012 401k financial data |
|---|
| Total income from all sources | 2012-12-31 | $1,595,434 |
| Expenses. Total of all expenses incurred | 2012-12-31 | $437,435 |
| Benefits paid (including direct rollovers) | 2012-12-31 | $436,731 |
| Total plan assets at end of year | 2012-12-31 | $8,139,190 |
| Total plan assets at beginning of year | 2012-12-31 | $6,981,191 |
| Value of fidelity bond covering the plan | 2012-12-31 | $500,000 |
| Total contributions received or receivable from participants | 2012-12-31 | $373,189 |
| Other income received | 2012-12-31 | $1,054,012 |
| Net income (gross income less expenses) | 2012-12-31 | $1,157,999 |
| Net plan assets at end of year (total assets less liabilities) | 2012-12-31 | $8,139,190 |
| Net plan assets at beginning of year (total assets less liabilities) | 2012-12-31 | $6,981,191 |
| Assets. Value of participant loans | 2012-12-31 | $67,912 |
| Total contributions received or receivable from employer(s) | 2012-12-31 | $168,233 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2012-12-31 | $704 |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2012-12-31 | $0 |
| 2011 : PARATEK PHARMACEUTICALS, INC. PROFIT SHARING 401(K) PLAN 2011 401k financial data |
|---|
| Total income from all sources | 2011-12-31 | $481,259 |
| Expenses. Total of all expenses incurred | 2011-12-31 | $571,903 |
| Benefits paid (including direct rollovers) | 2011-12-31 | $571,294 |
| Total plan assets at end of year | 2011-12-31 | $6,981,191 |
| Total plan assets at beginning of year | 2011-12-31 | $7,071,835 |
| Value of fidelity bond covering the plan | 2011-12-31 | $500,000 |
| Total contributions received or receivable from participants | 2011-12-31 | $446,204 |
| Contributions received from other sources (not participants or employers) | 2011-12-31 | $16,261 |
| Other income received | 2011-12-31 | $-189,885 |
| Net income (gross income less expenses) | 2011-12-31 | $-90,644 |
| Net plan assets at end of year (total assets less liabilities) | 2011-12-31 | $6,981,191 |
| Net plan assets at beginning of year (total assets less liabilities) | 2011-12-31 | $7,071,835 |
| Assets. Value of participant loans | 2011-12-31 | $41,416 |
| Total contributions received or receivable from employer(s) | 2011-12-31 | $208,679 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2011-12-31 | $609 |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2011-12-31 | $0 |
| 2010 : PARATEK PHARMACEUTICALS, INC. PROFIT SHARING 401(K) PLAN 2010 401k financial data |
|---|
| Total income from all sources | 2010-12-31 | $1,589,082 |
| Expenses. Total of all expenses incurred | 2010-12-31 | $364,980 |
| Benefits paid (including direct rollovers) | 2010-12-31 | $364,567 |
| Total plan assets at end of year | 2010-12-31 | $7,071,835 |
| Total plan assets at beginning of year | 2010-12-31 | $5,847,733 |
| Value of fidelity bond covering the plan | 2010-12-31 | $500,000 |
| Total contributions received or receivable from participants | 2010-12-31 | $459,870 |
| Other income received | 2010-12-31 | $919,507 |
| Net income (gross income less expenses) | 2010-12-31 | $1,224,102 |
| Net plan assets at end of year (total assets less liabilities) | 2010-12-31 | $7,071,835 |
| Net plan assets at beginning of year (total assets less liabilities) | 2010-12-31 | $5,847,733 |
| Assets. Value of participant loans | 2010-12-31 | $79,487 |
| Total contributions received or receivable from employer(s) | 2010-12-31 | $209,705 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2010-12-31 | $413 |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2010-12-31 | $0 |
| 2009 : PARATEK PHARMACEUTICALS, INC. PROFIT SHARING 401(K) PLAN 2009 401k financial data |
|---|
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2009-12-31 | $0 |
